ABSTRACT
INTRODUCTION
Incidence of optic nerve related ophthalmic disease is an important area for study as a host of conditions have the propensity to result in optic nerve damage, which often leads to irreversible vision loss and visual disability. Some of these processes are acute and may present with rapid visual deterioration (ischemic optic neuropathy, optic neuritis as examples), while others are more insidious and manifest over time (chronic open angle glaucoma). While these diseases may not initially present with optic nerve dysfunction in earlier stages on a clinical level, each disease process lends itself to compromise optic nerve integrity, resulting in optic nerve injury.
Mapping the incidence of pathologies of the optic nerve is essential to understanding the relative likelihood of these conditions and gives a framework upon which to target treatment. While several population-based studies have evaluated incidence and prevalence of various pathologic ophthalmic conditions one at a time [1] [2] [3] [4] [5] [6] , none have evaluated multiple disease processes in a diverse population base covering a large geographic area with rural and metropolitan components.
Electronic medical records (EMRs) offer the opportunity to glimpse at the health histories of millions of individuals without requiring centralized reporting of disease (i.e., registries). The focus of this paper is to characterize the incidence of five distinct ophthalmic conditions impacting the middle Tennessee area using the Vanderbilt University Medical Center (VUMC) anonymized (Synthetic Derivative) medical records.
We evaluate the incidence of ophthalmic conditions affecting optic nerve function in five major disease cohorts: glaucoma 5, [7] [8] [9] , intrinsic optic nerve disease 2, 6, [10] [11] [12] , optic nerve edema (and idiopathic intracranial hypertension) 3, 4, [13] [14] [15] , orbital inflammation [16] [17] [18] [19] , and thyroid disease 1, 20, 21 . The cohorts were investigated (as opposed to specific diagnoses)
to ensure reliable patient-group assignment across thousands of patients without expert chart review of individual patients.
METHODS

Study Population
Nashville and its surrounding suburbs make up the most densely populated area Therefore, reference population estimates from the census data were scaled accordingly (e.g., market-adjusted population). The protocol, compliant with the Health Insurance Portability and Accountability Act (HIPAA), was approved by the Institutional Review Board of Vanderbilt University. The study adhered to the tenets of the Declaration of Helsinki.
Data Collection
The ophthalmic conditions investigated in this study (glaucoma, intrinsic optic nerve disease, optic nerve edema, orbital inflammation, and thyroid disease) were defined by ICD-9 codes (Table 1) . De-identified demographics (age, sex, ethnicity, and race) and all ICD-9 events (date / code pairs) were retrieved for all patients with ICD-9 codes matching Table 1 (2) had initial diagnosis of one of the ICD-9 codes of interest within the time range, (3) resided in the geographical region of interest (zip code prefix of 370, 371, 372, 373, 374, 383, 384, and 385), and (4) had complete age and gender information. The data from 2014 was not included in the final analysis as all of the data from 2014 was not available. For the purposes of this study, the date of occurrence of a condition was defined as the date of the first ICD-9 code with a cohort.
Data Analysis and Statistical Methods
To ensure sufficient sample size, patients were binned according to 13 divided by 7 years for the complete study) by the estimated market-adjusted population (Fig. 1) . Note that this approach averages both the incidence and health care system "market share" metrics over a 7-year period as to minimize the impact of any year-toyear variations (e.g., change in number of physicians, insurance contract negotiations, and population growth). A 95% confidence interval was constructed for each incidence estimate based on the Poisson distribution. Fisher's exact test was used to calculate the significance of relative likelihood of gender, age, and race incidence.
A co-occurrence graph for the 79 ICD-9 codes ( 
Validation
A subset of 100 patients was selected with 20 subjects chosen uniformly at random from within each disease cohort. No duplicate subjects were selected across cohorts. Traditional expert chart review was performed to determine the frequency of coding errors to ascertain if the ICD-9 reflected the actual diagnostic state of the patients.
RESULTS
Race, Gender, and Age Distribution of Patients
Among the 3 397 515 residents of the defined area (market-adjusted population 1 321 255), a total of 18 779 diagnosis incidence events were found for 18 291 unique patients. This number corresponds to an age adjusted incidence of 168.1/100 000 residents (95% CI: 161.7-170.6).
The demographics of the patients in the cohort reflected the central Tennessee population with 1.5% Asian, 12.8% African American, <1% Native American, 80.8%
Caucasian, and 4.5% other/multi-racial/unknown with 2% Hispanic, 88% non-Hispanic, and 9% unknown. Tables 2-3 present the patient counts 
Incidence Findings
Incidence of each of the disease cohorts did not systematically differ across the time period of the study (e.g., lack of apparent trends in Supplementary Table 1 ). For the remainder of the analyses, the diagnoses are pooled across years and incidence is scaled to reflect the increased time period. Fig. 2 shows a co-occurrence graph for the 79 ICD-9 codes (Table 1) and table for the five cohorts.
Validation
For 94 of 100 patients, direct evidence of the reported ICD-9 code that led to cohort inclusion was found in the anonymized EMR (e.g., clinic notes, consult notes).
Scanned handwritten notes and Adobe Portable Document Format (PDF) notes, which constitute a subset of the clinic and consult notes, are not included in the anonymized EMR due to the difficultly in removing protected health information at scale. Hence, the anonymized EMR is incomplete. For 5 such patients with missing notes, sufficient indirect evidence (including multiple entries of ICD-9 codes, medications, referrals for a consult, lab reports, etc.) was found such that a practicing ophthalmologist was convinced that the patient was legitimately diagnosed with the ICD-9 code in the chart.
Finally, one patient had an entry of orbital cellulitis (ICD-9 376.01), but the chart showed periorbital cellulitis (ICD-9 373.13), which indicates a coding error sufficient so that the patient would have not met inclusion criteria for the orbital inflammation cohort.
Therefore, 99 of 100 samples yielded correct cohort groups. Under a binomial model, the exact confidence interval on error rate is 0.02% to 5.45%, with a mean of 1%.
DISCUSSION
This study provides insight into the incidence of multiple disease processes 
Glaucoma
Glaucoma was by far the greatest optic nerve disease burden in the greater TN population. Similar to other studies, the incidence of glaucoma in the middle TN population dramatically increases with age over 40 5 . We see this trend very clearly, with the steep increase of the relative incidence of Glaucoma after 50 in Supplemental Chronic open angle glaucoma is the most common cause of optic neuropathy in adults over the age of 40 and is estimated to affect 2.2 million Americans currently, with an estimated 3.36 million in 2020 5 . Race is a large factor in the risk of visual field loss and blindness from glaucoma. In a recent study, patients of African descent with the same access to care were shown to have a hazard ratio of up to 3.61 in the development of visual field loss at intraocular pressures greater than 22mm Hg, as compared to patients of European descent 26 . In our patient population, we found that glaucoma had only a slightly higher incidence in African American population (Odds Ratio=1.27).
Intrinsic Optic Nerve Disease
Disease related to the optic nerve other than glaucoma were pooled into an intrinsic optic nerve disease category and included optic neuritis, ischemic optic neuropathy, arteritic optic neuropathy. Optic neuritis most often affects young, Caucasian females, with a mean age of 32 27 with incidence of approximately 5 per 100 000 2 . Anterior ischemic neuropathy, including arteritic and non-arteritic subtypes, is the most common cause of acute optic neuropathy in adults over the age of 50. Its incidence has been reported at 2-10 per 100 000 10 . Arteritic anterior ischemic optic neuropathy comprises much fewer of the cases of anterior ischemic optic neuropathy (5-10%) and occurs most frequently in patients over 70 years old, with an estimated incidence of 10-19.8 per 100 000 patients 11, 12 and a peak incidence in women aged 70-79 11 By looking more broadly at the phenotype of optic neuropathies, we can appreciate population level trends with a great degree of accuracy. Notably, there is a moderate increase in incidence of optic neuropathy in females over males (13.5 versus 10.4 per 100 000). For both males and females, the incidence of optic neuropathy is low <35 years old and begins to increase with age. The overall levels of incidence are generally in agreement with the literature when factoring the multiple conditions captured in this cohort.
Optic Nerve Edema
The middle TN population cohort of patients with optic nerve edema included patients with idiopathic intracranial hypertension (IIH) and papilledema. Table 8 ).
Incidence in males peaked at 10-14 years old (14.0 per 100 000).
Orbital Inflammation
The category orbital inflammation includes a variety of conditions either from an infectious or idiopathic etiology to include orbital cellulitis, orbital myositis, orbital periostitis, dacryoadenitis, and non-specific orbital inflammation (NSOI), among others.
With the broad range of conditions that lead to orbital inflammation, systematic incidence studies of individual disease entities, or even pooled conditions as in this study, at a population level do not appear to have been conducted with some exception for example sarcoidosis in the veteran population 29 . An increased incidence of orbital infection has been associated with socioeconomic deprivation 30 . We find substantially higher incidences in children and African American population (Tables 10 and 11 ).
Thyroid Disease
We note that thyroid eye disease is not precisely / completely captured by ICD-9 diagnostic practices. Herein, we included 242.00 "Toxic diffuse goiter without mention of thyrotoxic crisis or storm" in the definition. While 242.00 includes eye disease resulting from hyperthyroidism, it is not specific. If we limit our consideration of thyroid eye disease to ICD-9 codes of 376.2*, these patients have definitive eye involvement, yet, only a small fraction of the eye patients would be found. For example, the 1523:388 patients in Supplementary Table 6 would drop to 139:50. Hence, this study presents the incidence of thyroid disease as a risk factor / prodromal aspect of thyroid eye disease.
In 31 , the authors found that 12.5% of thyroid patients present with eye involvement.
Therefore, it would be reasonable to divide the thyroid disease incidence estimates by eight to yield a conservative estimate of thyroid eye disease. per 100 000 population. A study performed by Bartley et al detailed the incidence of thyroid ophthalmopathy in a cohort of patients in Minnesota, yielding 16.0 cases per 100 000 population per year for women and 2.9 cases per 100 000 per year for men 1 .
Compared with Olmsted County, middle Tennessee is more diverse and more urban; substantially more thyroid disease patients were identified in this study (1 523 in 7 years versus 519 in 15 years). The overall incidence seen in this study was approximately two-fold higher (versus 16.0 per 100 000 for females and 2.9 per 100 000 for males).
We note that the Bartley study was based on manual chart review and excluded patients with hypothyroidism and Hashimoto's thyroiditis without ophthalmopathy, which could have resulted in a systematic bias between manual review and ICD-9 studies.
Moreover, diagnostic practices and technologies have substantively evolved in the two decades between these two studies. In summary, the current study indicates a substantially greater incidence of thyroid disease in the general population than previous studies have indicated.
Limitations and Conclusion
A central limitation of the study is that incidences are reflective of physician diagnostic standards and insurance coding practices, which are reasonable proxy for true disease occurrence, but not identical. Second, the population of the target areas is based on census data from a median year. We chose not to linearly interpolate between the census years (as in 12 ) given the growth of the Nashville area and hesitancy to extrapolate population beyond the census period; rather we pool across years as to level out inconsistencies due to systematic factors (i.e., those that may lead to year-byyear variations in market share). The lack of trends in incidence by year (Supp. Table 4) lends support to the selected study design methodology. Finally, the market share corrected population is based on reported inpatient data, whereas the patient cohorts are based on both inpatient and outpatient information. Outpatient information is not reportable to the state and is not available for institutions outside of the VUMC affiliated hospital network. If all patients had come to VUMC (and none to other hospital systems), incidence could not be less than a third of the reported values (1/0.389).
Hence, small errors in market share analyses translate to small errors in incidence estimates. Moreover, we find that coding errors are rare for our target population (approximately 1:100) and would not substantively impact the incidence estimates.
Importantly, these limitations are generally cohort-and demographic agnostic (i.e.,
would not substantively impact the reporting of one condition relative to another or one patient versus another). Therefore, we have high confidence in the incidence comparisons within and across Supplemental Tables (e.g., males versus females, age groups, optic nerve disease versus orbital inflammation).
In conclusion, this manuscript has characterized the incidence of five important sets of pathological conditions that impact the optic nerve through use of anonymized EMRs. In contrast to several previous studies, we estimate the incidence of conditions that are known to lead to optic nerve damage as opposed to incidence of optic nerve damage concomitant with diagnosis of a condition. The incidences reported in this study are generally higher than could be understood from the literature when individual conditions were more narrowly defined, or when incidence studies were performed in less diverse settings. Moreover, the reported incidence rates are reflective of current diagnostic technologies and practices. Hence, this study serves as an important update on the incidence of conditions that impact the optic nerve with demographics reflective of the US population (with a slight under-sampling of Asian and Hispanic and oversampling of African American). Fig. 1 . Flowchart of calculation of average incidence per 100 000. , where P(A) is the probability of having diagnosis A, and P(A, B) is the probability of having both diagnosis A and B. The graph was created by calculating the DC measure for all 6 241 pairs of 25 ICD9 codes. The graph clustering was performed using ForceAtlas2 algorithm. The ForceAtlas2 algorithm computes attraction and repulsion forces proportional to the weights of the edges (DC measures) such that nodes with high co-occurrence are clustered closer together, while nodes with low co-occurrence are further away from each other. ICD-9 codes within a cohort have a very high co-occurrence, however there is overlap between diagnoses cohorts as well, as quantitatively shown in the table at right. In (B), each entry of the table shows the probability of a patient having the column condition given that they have the condition in the row. 
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